Synapticure

Synapticure is a Chicago-based teleneurology company founded in 2019. It provides virtual care platforms and services for patients and caregivers dealing with neurodegenerative diseases, including ALS, Alzheimer's, Parkinson's, and other movement disorders. The company operates a telemedicine model that offers nationwide access to expert neurologists and in-home research capabilities, partnering with leading ALS clinics like Massachusetts General Hospital and the University of California San Francisco. The mission of Synapticure is to enhance access to expert-led care and support, particularly for rural and underserved communities. Its services include consultations with neurologists, mental health support, care coordination, and proactive monitoring to prevent care gaps. The platform also facilitates clinical research and collaborates with care teams to identify high-risk patients and implement optimal interventions. Synapticure has raised $31 million in funding and serves several thousand patients across the U.S.